Board of Directors
Gordon Sato, PhD | Co-Founder & Chairman of the Board, A&G Pharmaceutical
Lars Hanan, MBA | Co-Founder and Managing Partner, BroadOak Capital Partners
Lars Hanan is a co-founder and Managing Partner of BroadOak Capital Partners. With 20 years of experience in corporate finance and mergers and acquisitions, Mr. Hanan has executed more than 100 transactions in a broad range of industries. Prior to BroadOak, he built and managed the life sciences advisory business at Mercator Capital. Before that, he headed the M&A Group at ABN AMRO Investment Banking, where he was responsible for the Healthcare M&A practice, with particular sector expertise in medical technology and drug discovery tools. Mr. Hanan was previously Head of Mergers & Acquisitions for SG Cowen’s Media Group and held senior mergers and acquisitions positions at Kidder, Peabody and at Lehman Brothers. He serves on the board of directors of Marligen Biosciences, A&G Pharmaceutical, and Noxilizer. Mr. Hanan received a BA in Economics from the University of Virginia and an MBA from the J.L. Kellogg School of Management at Northwestern University.
Tom Hancock | Principal, New England Partners/Nexus Medical Partners Fund
SeungSuh “Stanley” Hong, PhD | Vice President of Business Development, Celltrion
Jennie Mather, PhD | Senior Vice President, Stem Cell Research, MacroGenics
Ginette Serrero, PhD | Co-Founder and CEO
Seung Il-Shin, PhD | Founder, Celltrion
Gordon Sato, PhD | Co-Founder & Chairman of the Board, A&G Pharmaceutical
Lars Hanan, MBA | Co-Founder and Managing Partner, BroadOak Capital Partners
Lars Hanan is a co-founder and Managing Partner of BroadOak Capital Partners. With 20 years of experience in corporate finance and mergers and acquisitions, Mr. Hanan has executed more than 100 transactions in a broad range of industries. Prior to BroadOak, he built and managed the life sciences advisory business at Mercator Capital. Before that, he headed the M&A Group at ABN AMRO Investment Banking, where he was responsible for the Healthcare M&A practice, with particular sector expertise in medical technology and drug discovery tools. Mr. Hanan was previously Head of Mergers & Acquisitions for SG Cowen’s Media Group and held senior mergers and acquisitions positions at Kidder, Peabody and at Lehman Brothers. He serves on the board of directors of Marligen Biosciences, A&G Pharmaceutical, and Noxilizer. Mr. Hanan received a BA in Economics from the University of Virginia and an MBA from the J.L. Kellogg School of Management at Northwestern University.
Tom Hancock | Principal, New England Partners/Nexus Medical Partners Fund
SeungSuh “Stanley” Hong, PhD | Vice President of Business Development, Celltrion
Jennie Mather, PhD | Senior Vice President, Stem Cell Research, MacroGenics
Ginette Serrero, PhD | Co-Founder and CEO
Seung Il-Shin, PhD | Founder, Celltrion
© 2009 A&G Pharmaceutical, Inc. All Rights Reserved. | Terms of Use | Privacy
